DK2470230T4 - Viskoelastiske geler som nye fyldstoffer - Google Patents

Viskoelastiske geler som nye fyldstoffer Download PDF

Info

Publication number
DK2470230T4
DK2470230T4 DK10750046.4T DK10750046T DK2470230T4 DK 2470230 T4 DK2470230 T4 DK 2470230T4 DK 10750046 T DK10750046 T DK 10750046T DK 2470230 T4 DK2470230 T4 DK 2470230T4
Authority
DK
Denmark
Prior art keywords
viscoelastic gels
new fillers
fillers
new
viscoelastic
Prior art date
Application number
DK10750046.4T
Other languages
English (en)
Other versions
DK2470230T3 (da
Inventor
Matteo D'este
Davide Renier
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42046298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2470230(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Application granted granted Critical
Publication of DK2470230T3 publication Critical patent/DK2470230T3/da
Publication of DK2470230T4 publication Critical patent/DK2470230T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/005—Processes for mixing polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/14—Powdering or granulating by precipitation from solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK10750046.4T 2009-08-27 2010-08-25 Viskoelastiske geler som nye fyldstoffer DK2470230T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITPD2009A000246A IT1395392B1 (it) 2009-08-27 2009-08-27 Geli viscoelastici come nuovi filler
PCT/EP2010/005161 WO2011023355A2 (en) 2009-08-27 2010-08-25 Viscoelastic gels as novel fillers

Publications (2)

Publication Number Publication Date
DK2470230T3 DK2470230T3 (da) 2014-10-06
DK2470230T4 true DK2470230T4 (da) 2022-08-01

Family

ID=42046298

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14170084.9T DK2772273T3 (da) 2009-08-27 2010-08-25 Viskoelastiske geler som nye fyldmaterialer
DK10750046.4T DK2470230T4 (da) 2009-08-27 2010-08-25 Viskoelastiske geler som nye fyldstoffer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14170084.9T DK2772273T3 (da) 2009-08-27 2010-08-25 Viskoelastiske geler som nye fyldmaterialer

Country Status (22)

Country Link
US (1) US8846640B2 (da)
EP (2) EP2772273B9 (da)
JP (1) JP5976537B2 (da)
KR (1) KR101749660B1 (da)
CN (2) CN104623730B (da)
AU (1) AU2010288937B2 (da)
BR (1) BR112012004157B8 (da)
CA (2) CA2772142C (da)
CY (2) CY1115628T1 (da)
DK (2) DK2772273T3 (da)
ES (2) ES2509225T5 (da)
HK (2) HK1172850A1 (da)
HR (2) HRP20140981T4 (da)
HU (1) HUE026830T2 (da)
IT (1) IT1395392B1 (da)
MX (1) MX2012002364A (da)
PL (2) PL2470230T5 (da)
PT (1) PT2470230E (da)
RU (2) RU2543329C2 (da)
SI (2) SI2772273T1 (da)
SM (1) SMT201600062B (da)
WO (1) WO2011023355A2 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0819075A2 (pt) 2007-11-16 2014-10-07 Vicept Therapeutics Inc Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
WO2011110894A2 (en) 2010-03-12 2011-09-15 Allergan Industrie Sas Fluid composition for improving skin conditions
PL3078388T3 (pl) 2010-03-22 2019-08-30 Allergan, Inc. Usieciowane hydrożele do powiększania tkanek miękkich
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102015676B1 (ko) 2011-06-03 2019-10-21 알러간, 인코포레이티드 항산화제를 포함하는 피부 충전제 조성물
ES2899992T3 (es) * 2011-08-10 2022-03-15 Glycores 2000 Srl Acido hialurónico reticulado de bajo peso molecular resistente a la degradación
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CN104105474B (zh) * 2011-09-14 2018-04-06 阿勒根公司 用于细纹治疗的真皮填充剂组合物
KR101428145B1 (ko) * 2011-11-24 2014-08-08 (주)아모레퍼시픽 수불용성 겔 조성물 및 그 제조방법
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITMI20120732A1 (it) * 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
JP6174690B2 (ja) * 2012-06-15 2017-08-02 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ヒアルロン酸に基づく組成物の調製方法
FR2997085B1 (fr) * 2012-10-24 2015-05-29 Teoxane Procede de preparation d'un gel reticule
ITPD20120360A1 (it) * 2012-11-30 2014-05-31 Fidia Farmaceutici "nuovi geli viscoelastici in chirurgia oftalmica"
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
ITPD20130110A1 (it) * 2013-04-24 2014-10-25 Fidia Farmaceutici Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
MX368941B (es) * 2013-06-28 2019-10-22 Galderma Sa Un procedimiento para preparar un producto de ácido hialurónico entrelazado.
WO2015005345A1 (ja) * 2013-07-08 2015-01-15 電気化学工業株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
EP3035903B1 (en) 2013-08-20 2018-08-22 Anutra Medical, Inc. Syringe fill system and method
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
RU2610006C1 (ru) * 2016-03-23 2017-02-07 Наталья Павловна Михайлова Способ липотерапии
CA3033536A1 (en) 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
EP3609483A4 (en) * 2017-04-12 2021-01-20 Urigen Pharmaceuticals, Inc. ITEM OF MANUFACTURING CONSISTING OF LOCAL ANESTHETICS, BUFFER AND GLYCOSAMINOGLYCANE IN A SYRINGE OF IMPROVED STABILITY
MX2020006651A (es) * 2017-12-22 2020-11-06 Nestle Skin Health Sa Producto inyectable en gel.
PL3731808T3 (pl) * 2017-12-29 2024-03-18 Matex Lab S.P.A. Sposób przygotowania wypełniacza na bazie kwasu hialuronowego obejmujący etap zobojętnienia
IT201800001890A1 (it) 2018-01-25 2019-07-25 Fidia Farm Spa Composizioni farmaceutiche per il trattamento del dolore postoperatorio
WO2020184744A1 (ko) * 2019-03-08 2020-09-17 주식회사 지씨에스 복합체의 제조 방법
IT202000005692A1 (it) 2020-03-17 2021-09-17 Fidia Farm Spa Bio-inchiostro per stampa 3D, relativo coniugato e processo di preparazione di un intermedio costituito da un linker fotoreattivo
KR102417671B1 (ko) * 2020-04-28 2022-07-06 충남대학교산학협력단 자가가교 시스템을 가지는 히알루론산 기반 연조직 충전 조성물 및 이의 제조방법
RU2746877C1 (ru) * 2020-07-23 2021-04-21 Роман Дмитриевич Лебедев Пористый фильтрующий элемент и способ его изготовления
KR102640893B1 (ko) * 2021-11-12 2024-02-27 주식회사 유영제약 히알루론산 가교물을 포함하는 조성물의 제조방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
IT1288290B1 (it) * 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
IT1296689B1 (it) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
CA2567532C (en) * 2004-05-20 2013-10-01 Mentor Corporation Methods for making injectable polymer hydrogels
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
ITPD20050146A1 (it) * 2005-05-20 2006-11-21 Fidia Farmaceutici Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP5165281B2 (ja) * 2007-06-01 2013-03-21 株式会社バイオベルデ ２反応剤型の医療用含水ゲル形成剤、及び、これより得られるヒアルロン酸ゲル
FR2918377B1 (fr) * 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
ATE544786T1 (de) † 2007-09-28 2012-02-15 Shiseido Co Ltd Quellbares vernetztes hyaluronsäurepulver und herstellungsverfahren dafür
WO2009043111A1 (en) * 2007-10-04 2009-04-09 Ultraceuticals R & D Pty Ltd Composition and method for dermal regeneration
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2924615B1 (fr) * 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
US9109051B2 (en) * 2007-12-19 2015-08-18 Evonik Goldschmidt Gmbh Crosslinked hyaluronic acid in emulsion
CN101538377A (zh) † 2008-03-20 2009-09-23 上海昊海生物科技有限公司 一种交联透明质酸凝胶及其制备方法
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine

Also Published As

Publication number Publication date
ITPD20090246A1 (it) 2011-02-28
PL2772273T3 (pl) 2016-05-31
HK1172850A1 (en) 2013-05-03
HK1196787A1 (zh) 2014-12-24
SI2470230T1 (sl) 2014-11-28
PT2470230E (pt) 2014-10-07
SI2470230T2 (sl) 2022-09-30
CA2995957A1 (en) 2011-03-03
RU2012106800A (ru) 2013-08-27
RU2692800C2 (ru) 2019-06-27
CN102548590A (zh) 2012-07-04
HRP20140981T1 (en) 2014-11-21
CA2995957C (en) 2020-04-28
RU2014149799A3 (da) 2018-08-28
JP2013502941A (ja) 2013-01-31
PL2470230T3 (pl) 2015-02-27
BR112012004157B1 (pt) 2021-03-09
MX2012002364A (es) 2012-03-29
RU2014149799A (ru) 2016-07-10
US8846640B2 (en) 2014-09-30
EP2470230B1 (en) 2014-07-23
ES2563160T3 (es) 2016-03-11
ES2509225T5 (es) 2022-09-29
RU2543329C2 (ru) 2015-02-27
BR112012004157B8 (pt) 2021-06-22
HRP20140981T4 (hr) 2022-08-19
SI2772273T1 (sl) 2016-04-29
HRP20160196T1 (hr) 2016-03-25
US20120190644A1 (en) 2012-07-26
HUE026830T2 (en) 2016-07-28
EP2470230A2 (en) 2012-07-04
SMT201600062B (it) 2016-04-29
EP2772273A3 (en) 2014-12-03
EP2772273B1 (en) 2015-12-02
CN104623730A (zh) 2015-05-20
AU2010288937B2 (en) 2015-03-05
EP2470230B2 (en) 2022-07-06
CN102548590B (zh) 2015-02-25
HRP20140981T8 (en) 2015-01-16
CA2772142A1 (en) 2011-03-03
DK2772273T3 (da) 2016-03-07
AU2010288937A1 (en) 2012-03-15
CN104623730B (zh) 2016-11-16
WO2011023355A3 (en) 2011-10-27
HRP20140981T2 (hr) 2016-05-06
PL2470230T5 (pl) 2022-10-31
EP2772273A2 (en) 2014-09-03
KR101749660B1 (ko) 2017-06-21
DK2470230T3 (da) 2014-10-06
EP2772273B9 (en) 2016-05-18
CY1115628T1 (el) 2017-01-04
IT1395392B1 (it) 2012-09-14
KR20120107455A (ko) 2012-10-02
JP5976537B2 (ja) 2016-08-23
CY1117207T1 (el) 2017-04-05
ES2509225T3 (es) 2014-10-17
CA2772142C (en) 2018-04-10
WO2011023355A2 (en) 2011-03-03
BR112012004157A2 (pt) 2020-08-11

Similar Documents

Publication Publication Date Title
DK2470230T3 (da) Viskoelastiske geler som nye fyldmaterialer
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
DK2364293T3 (da) Hidtil ukendte pyrazol-4-N-alkoxycarboxamider som mikrobiocider
DK2369934T3 (da) Spiroheterocykliske n-oxypiperidiner som pesticider
BRPI1006128A2 (pt) derivados de sulfonamida
BRPI1008774A2 (pt) espiroamida substituída
DOP2011000396A (es) Composiciones novedosas
DK2061766T3 (da) Nye forbindelser
DK2310501T3 (da) Nye regulatoriske elementer
ECSP12011999A (es) Derivados benzamida sustituidos
DE112010004108A5 (de) Rotationsviskosimeter
DK2397480T3 (da) Diazepindionderivat
DK3070091T3 (da) Benzodioxolderivater som phosphodiesterasehæmmere
DK2234976T3 (da) Nye pyrazol-substituerede arylamider
BR112012000657A2 (pt) novos azabicilohexanos
DK2387580T3 (da) Deoxyactagardinderivater
ECSP12011977A (es) Derivados de etinilo
BRPI1011416A2 (pt) derivados de antraquinova novos
BRPI1007245A2 (pt) composição polimérica
BRPI1012775A2 (pt) piperidinas substituídas
DE102009005916A8 (de) Schraube
DK2394638T3 (da) Nye farmaceutiske sammensætninger
DK2248722T3 (da) Palleløs emballeringsenhed
DK2536712T3 (da) Oligothiophenderivat som molekulære sonder
DK2456765T3 (da) Imidazolderivater som mglur5-antagonister